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INTRODUCTION
Congress enacted the rstfederal food and drug law in 1906, and broadened
the (Food and Drug Administration l's responsibilities In the 1930s with an
expansive denition of drugs that included substances intended by their makers
to aect the structure orfunction of the body.'
Since the I 930s the Food and Drug Administration (FDA) has taken broad
Jurisdiction over eveiyday products in an attempt to ensure public health. De-
spite that mission, the FDA In particular and the Federal government In general
has done little to regulate the tobacco Industry. Recently, however, the Com-
missioner of the FDA, Dr. David A. Kessler. raised the possibility of regulating
the cigarette Industry.2 But is the simple regulation of cigarettes permitted by
the Federal Food, Drug and Cosmetic Act of 1938, which grants the FDA ju-
risdiction over products? Given the unanimity of opinion on the hazards of
cigarette smoking, the answer to this question is no, and yet the conclusion
that cigarettes must be banned seems too radical to seriously imagine. As a
result, the context in which the FDA has approached cigarette smoking should
be analyzed.
Public health ocials and other health advocates have long warned our
society of the dangers of smoking.3 Tobacco is the major cause of
Schwartz, 'FDA Targets 'Nicotine-Delivery Systems': Kessler's Agency Be-
latedly Zeroes In On Drug In Cigarettes, WASH. POST, May 31, 1994, at Al.
2 Testimony to Chairman Henry Waxinan's Subcommittee on Health and the
Environment of the House Energy & Commerce Conniuttee on March 25, 1994.
See aLso Letter from FDA Commissioner Dr. David A. Kessler to the Chair-
man of the Coalition on Smoking OR Health (Feb. 25, 1994).
~ Tobacco products' hazards are recognized to exist beyond reasonable scien-
tic dispute. O'Reilly, A Consistent Ethic of Safety Regulation: The Case for
Improving Regulation of Tobacco products, 3 Admin. L.J. 215, 216 (1989). See
also U.S. Department of Health and Human ServIces, THE HEALTH CONSE-
QUENCES OF SMOKING: NICOTINE ADDICTION- A REPORT OF THE
SURGEON GENERAL, at 1(1988) (highlighting that ic]igarettes and other
forms of tobacco are addicting, [nilcotine is the drug in tobacco that causes
addiction, [andi Itihe pharmacologic and behavioral processes that determine
tobacco addiction are similar to those that determine addiction to drugs such
as heroin and cocaine.); Wynder, Tobacco and Health: A Review of the History
and Suggestions for Public Health Policy, 103 PUB.
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American adult respiratory illness, including lung cancer, heart disease, and
related problems.4 In fact, tobacco related illnesses are the United States's ma-
jor avoidable health problem.5 In recent years, this message has resonated with
the American public and widespread regulation of smoking has been enacted at
the local level.6 Ordinances have been adopted all over the country which ban
or restrict smoking in public places, such as restaurants and government oces.
At the federal level, however, the story has been very dierent: IDlespite its
well-established risks, tobacco has been untouchable at the federal level, due
to, among other things, the inuence of the poweul tobacco lobby, the loyal-
ties of congressional lawmakers from tobacco-producing states, and continued
consumer demand for tobacco products.7
Generally, regulation is a systematic method of risk control which is used
as an alternative to the tort system for situations In which excessive costs or
minimal net benets result from our slow and costly tort system.8
HEALTH REP. 8 (Jan./Feb. 1988) (discussing background of a 1950 study
of the eects of tobacco that showed cigarette smoking plays an important part
in the etiology of lung cancer,
~ O'Reilly, supra note 3, at 218. See also U.S. Surgeon General, THE
HEALTH CONSEQUENCES OF SMOKING: CANCER AND Cl-IRONIC LUNG
DISEASE IN THE WORKPLACE- A REPORT OF THE SURGEON GEN-
ERAL 1, 7 (1985); Benowitz, Pharmacologic Aspects of Cigarette Smoking and
Nicotine Addiction, 319 NEw ENG. J. MED. 1318(1988) (stating that cigarette
smoking is major risk factor for heart disease, stroke, and several types of can-
cers); U.S. Department of Health and Human Services, BIBLIOGRAPHY ON
SMOKING AND HEALTH (1987) (containing a comprehensive bibliography of
data sources establishing the eects of tobacco use).
O'Reilly, supra note 3, at 218.
6 Clmons, Federal Control of Tobacco: A Smoldering Issue Heats Up, L.A.
TIMES, March 25,
1992, at AS.
Id.
~ O'Reilly, supra note 3, at 217. PolicIes favoring the use of regulation may...
be justied by the information defects aecting the ways in which consumers
can avoid injury, or may be justied by the spillover costs which are paid by
society as a whole when the product injures a consumer who then draws on
public assistance or social insurance funds, instead of attributing all costs back
to the product manufacturer who created the risks. Id, at 253 n.39 (citing
Breyer & Stewart, ADMINISTRATIVE LAW AND REGULATORY POLICY
14-20 (1985)). See also Pierce, Shapiro, & Verkuil, ADMINISTRATIVE LAW
& PRoCESs 11(1985) (asserting that regulation may also be used to address
market failure in an inecient market); Walsh &
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With respect to tobacco, individual consumers who are Injured by the prod-
uct's eects cannot force industry participants to change their products through
deterrence in the form of individual tort litigation. 'Tort law oers the Injured
tobacco user high costs of gathering information and virtually no chance of ex-
pecting deterrence of Injuries even if recovery could be obtained In tort.9 Reg-
ulation, on the other hand, has lower information costs and obvious deterrent
eects, and, therefore, Is much more appealing to the federal ocial concerned
about the eects of cigarette smoking.'0
Loc~ REGULATION
As previously discussed, local regulation of smoking has been generally ac-
cepted In this country for some time. Given the obvious risks and irritation
of second-hand smoking, local governments have sought to conne smoking to
areas that are either ventilated, isolated, or, at the very least, clearly designated
as smoking areas. Using the health of the general public as a motivation, local
governments have used their broad police powers to limit smoking, but have not
attempted to sanction tobacco producers, due to lack of jurisdiction and, more
importantly, sucient political power.
STAin REGULATION
Each state could, theoretically, adopt a system of regulation of cigarettes
as long as it was consistent with the state and federal constitutions. Such an
approach, though consistent with the U.S.
Klein, The Conicting Objectives of Federal and State Tort Law Drug Reg-
ulation. 41 FoOD DRUG COSM. L.J. 171(1986).
~ O'Reilly, supra note 3, at 217. See also Singer, Cigarette Papers, 10
AMER. LAw. 91, 93 (May 1988) (stating that the cost of one major case was
$1,750,000 for plaintis, with $600,000 in expert witness costs).
10 Health ociaLs blame smoking for an estimated 434,000 deaths annually.
Chen, In Shift, FDA Says It Could Classify Nicotine as a Drug, L.A. TIMES,
Feb. 26, 1994, at Al. See O'Reilly, supra note 3, at 244.
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Constitution's 10th Amendment,12 would almost certainly have devastating
eects in terms of transaction costs (especIally those of enforcement) and on
individuals who are addicted to the habit of smoking.13 One could certainly
foresee the tyranny of the majority creating smoking and non-smoking states, as
well as the temptation for tobacco industry to get even more nancially involved
in state legislative politics. It Is clear, however, that such a program would be
dicult to implement and the health benets would be seriously uneven.
METhODS OF FEDERAL REGULATION
Jurisdiction over the tobacco Industry can be gained by Congress through
the Federal Commerce Power contained in U.S. CoNsT. Art. [,.x 8.'~ Because
tobacco is a product produced in mass quantities by a relatively small number
of states, almost all tobacco is shipped over state lines and, therefore, subject to
regulation by Congress. Given that strong basis for jurisdiction, it is surprising
that the federal legislature's restrictions on smoking have been so limited.'5 The
most well-known federal restriction to
12 iTihe powers not delegated to the United States by the Constitution, nor
prohibited by it to the States, are reserved to the States respectively, or to the
People. U.S. CONST. Amend. X.
Reserving for the moment the question of nicotine addiction.
Congress has the power to regulate Commerce ... among the several states. U.S.
CONST. Art. I, x 8
Though given the strength of the tobacco lobby, the 700,000 American jobs that
are directly related to tobacco, the 46 mIllion smoking American citizens, and
the relative strength of tobacco state legislators, it may not be so surprising.
See Quindlen, Smoking, Health, Congress and a Canny FDA Chief, CHIC.
TRIBUNE, March 4, 1994, at 23. As a poignant example of the inability to
regulate tobacco, compare the absence of FDA control over tobacco, which is
related causally to premature deaths among one out of six persons who die each
year, with the outright ban on cancer-causing agents in colorants, although such
colorants may have less than a one-in-one-million lifetime additional cancer risk.
Seligman, Don't Bet Against Cigarette Makers, Fortune, Aug. 17, 1987, at 70-7
1. See also Public Citizen v. Young, 831 F.2d 1108, 1111 (D.C. CIr. 1987), cert
denIed, 108 S.Ct. 1470 (1988) (comparing eect of dyes with one-in-one-million
risk of causing cancer to one-in-200,000 risk of average male smoker's developing
cancer).
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date on cigarette smoking has been the ban on smoking on certain airline
routes and the mandatory installation of smoke detectors in airplane lavatories.
The lack of federal regulation on cigarette smoking has certainly not been
due to a shortage of possible methods of regulation at the disposal of the Ex-
ecutive branch.'6 I will examine four of them: the Controlled Substances Act,
the Federal Hazardous Substances Act, The Federal Food, Drug, and Cosmetic
Act's Device Regulations, and the Federal Food, Drug, and Cosmetic Act's Drug
Regulations.'7
CONThOLLED SUBSTANCES ACT
One method of regulating tobacco would be to declare tobacco a controlled
substance under the Controlled Substances Act (CSA). Given the 1988 Sur-
geon General's nding that tobacco is an addictive substance,'8 this would seem
proper and would bring cigarettes into the control of the Drug Enforcement Ad-
ministration, rather than the FDA.'9 However, the
In addition, Congress has been urged to allow the Public Health Service to
have administrative authority over the tobacco industry, but it has not done so.
H.R. REP. No.
449. 89th Cong., 1st Sess. 2-3. reprinted in 1965 U.S. CODE
CONG. & ADMIN. NEWS 2350,
2357-58. A House subcommittee voted 9-5 on Nov. 18, 1987 not to delete
the tobacco exemption in the Consumer ~oduct Safety Act. 1987 CONG. Q.
ALMANAC 356 (1987). As a relevant aside, House members were paid $104,000
in speaking fees by the Tobacco institute in 1988. O'Reilly, supra note 3, at 253
n.40 (citing Sarasohn, Luring Legislators, LEGAL TIMES. June 5, 1989, at 4).
'~ This discussion is meant to highlight the diculty of Kessler's current attempt
to regulate cigarettes.
'~' THE HEALTH CONSEQUENCES OF SMOKING: NICOTINE ADDICTION-
A REPORT OF THE SURGEON GENERAL, supra note 3. See also Schwartz,
FDA Panel says Nicotine is Addictive, WASH. POST. Aug. 3, 1994, at Al (FDA
Panel unanimously voted that the amount of nicotine delivered by currently
marketed cigarettes lisi likely to lead to addiction in the typical smoker); Infra,
discussion of addIction, 12-14.
'~ This approach has the other, perhaps fatal, drawback that the DEA is
akeady vastly overburdened with the War on Drugs. O'Reilly, supra note 3, at
240.
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Congress has granted a explicit exemption to the cigarette industry from the
CSA, so, without congressional action, such an approach is bound to fail.20
FEDERAL HAZARDOUS SUBSTANCES ACT
Another regulatory approach would be to declare cigarettes as consisting
of hazardous substances, as dened in the Federal Hazardous Substances Act
(FHSA). Though it has been found by a past Commissioner and Assistant Gen-
eral Counsel of FDA that FHSA cannot be applied to tobacco without the
consent of Congress,2' such an approach ignores the reality that some of the
substances that are contained in tobacco may be considered hazardous sub-
stances as dened in section 2(g) of the Act?2 The unwillingness of FDA in
1972 to assume jurisdiction under the FHSA was based on the assumption that
Congress's enactment of the Federal Cigarette Labeling and Advertising Act of
1965 and the Public Health Cigarette Smoking Act of 1970 demonstrated an
intent not to include tobacco under FHSA?2 While politically prudent, it can
be argued that this interpretation was a violation of the FDA's duty to ensure
public health. The adoption of subsequent legislation that governs a substance
does not Invalidate the
20 I have consciously omitted several other pieces of legislation, such as the
Consumer ~oduct Safety Act and the Toxic Substances Control Act, which have
explicit exemptions for
tobacco. The problem of requiring further Congressional action is common
across these pieces of legislation.
21 Hearings on 5. 1454 Before the Consumer Subcomm., 92nd Cong., 2nd
Sess. 242. 245 (1972) (statements by Dr. Charles C. Edwards, FDA Commis-
sioner, and Peter Barton Hutt, Assistant General Counsel for Food, Drugs, and
~oduct Safety Division of FDA).
22 Id.. at 245 (statement of Mr. Huti).
23 Id., at 242 (statement of Dr. Edwards).
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ability of previous legislation to gain authority over such a substance, unless
so explicitly stated.24
Though not favored by history or the FDA. FHSA's approach is appealing
given the traditional lack of control over both tobacco itself and the substances
added to cigarettes (which were not known, even to the public health agencies,
for many years). A little more than a decade ago, under pressure from public
health advocates, tobacco companies agreed to supply the Department of Health
and Human Services with a complete list of ingredients that was to be checked
for safety (though the list was kept from the public to prevent the revelation
of trade secrets)?2 Recognizing that this supposed guarantee of public health
was doing little or nothing to curb the addition of hazardous substances, health
advocates widely publicized the fact that cigarette smoke was found to contain
acetone, ammonia, arsenic, benzene, carbon monoxide, and cyanide, which are
all poisonous in sucient amounts?'~
To further deect public criticism, RJR Reynolds recently released a list of
some 600 substances contained in or added to cigarettes.27 Industry ocials said
the list proved that nothing added to tobacco products is
24 assume that there is no explicit exemption for tobacco due to the lack
of any citation in the hearing. It Is, however, suggested by the Department of
HEW that the legislative history of FHSA demonstrates a lack of contemplation
of cigarettes. Id. at 240 (statement of Dr. Edwards). This point seems to me
to be irrelevant because, in no way, does it matter what form these hazardous
substances are in as long as they aect public health. It appears to me that
such an approach is an excuse not to govern cigarettes, rather than a valid
interpretation.
25 Schwartz, 1981 Report on Tobacco is Released Nicotine Study Seems to
Contradict Claims, WASH. POST, April 14, 1994, at A3. See Let Congress
Break the Tobacco Habit. CHIC. TRIBUNE, July 5, 1994, at 14 (While Ito-
baccol companies complain of being overregulated, cigarettes themselves are
largely unregulated. The only people who know what goes into them are the
manufacturers.).
Monk, Nicotine Boosting Alleged: FDA Head Tells of Cigarette Plot, DE-
TROIT FREE PRESS, June22, 1994, atAl.
27 Schwartz, supra note 25, at A3.
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unsafe. RJR had previously asked six outside toxicologists to review the
substances. The panel reported that the substances are not hazardous to the
consumer in the manner In which they are used nor are they hazardous in the
amounts In which they are used.~ This nding is In direct conct with the
statement of former FDA Assistant General Counsel Hutt:
If cigarettes were placed under [FHSAJ... I think the [Commissioner] and
I would agree that they would then fall within the denition of toxic in sec-
tion 2(g) of the act, in that they would produce illness as a result of inhala-
tion. The only determination we would then be in a position to make [un-
der section 2(q) of the act] would be whether cigarettes would be required
to be banned under the banned hazardous substances provision.... [Tihere is
no one who knows what a safe level of inhalation of cigarette smoke or com-
ponents is. As a result, if the Congress did place cigarettes under the FHSA,
we would have no alternative but to declare them banned hazardous substances and make them iliegalf~
Given the resistance of the FDA to apply the FHSA, it is unlikely that the
FHSA, as currently constituted, provides a sucient vehicle to regulate tobacco
products. In addition to recognizing this reality, the public health community
has noted the diculty of demonstrating conclusively that obviously minuscule
amounts of dangerous ingredients in tobacco are Insucient to take a product
as popular as cigarettes o the market2'~
FEDERAL FOOD, DRUG, AND COSMETIC ACT OF 1938
In 1972, FDA Commissioner Dr. Charles C. Edwards gave his Interpreta-
tion of the Federal Food, Drug, and Cosmetic Act (FD&C Act) authority over
cigarettes:
Cigarettes and other tobacco products would be drugs subject to the [FD&C
Act] if medical claims are made for the product. United States v.46 Cartons...
Fairfax Cigarettes, 113 F.Supp. 336 (1952). We have on occasion proceeded
against cigarettes recommended for use in controlling appetite or otherwise rec-
ommended as a weight reducing aid. United States v. 354 Bulk Cartons...
Trim Reducing Aid CIgarettes, 178 F.Supp. 847(1959). However, cigarettes
recommended for smoking pleasure are
28 Id.
29 Statement of Mr. Hutt, supra note 21, at 245 (emphasis added).
30 See Schwartz, supra note 25, at A3.
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beyond the [FD&C Act]. In Federal Trade Commission v. Llggett and Myers
Tobacco Com1rxzny, 108 F.Supp. 573 (1952), it was held that cigarettes are not
drugs within the meaning of the act unless a therapeutic purpose is claimed. In-
deed, if cigarettes were to be classied as drugs, they would have to be removed from the market because It would be Impossible to prove they
were safe for their intended use.
Until Dr. Kessler's statement to Congress 22 years later, this statement, for
all practical purposes, remained the approach of the FDA.32
On May 26, 1977, a coalition of anti-smoking groups led by an organization
called Action on Smoking and Health (ASH) led a citizen petition with the
FDA requesting that the agency assert jurisdiction over cigarettes as a drug or
device; that the FDA regulate cigarettes no less strictly than It did saccharin,
and that the agency restrict the sale of cigarettes to pharmacies. ~ FDA Com-
missioner Donald Kennedy refused to assert such jurisdiction based on the same
rationale as his predecessor Dr. Edwards had 5 years earlier. In response to the
contention of the petitioners that cigarettes fall squarely within the statutory
denition,~ Kennedy responded:
The petitioners have presented no evidence that manufacturers or vendors
of cigarettes represent that the cigarettes are intended to aect the structure
or any function of the body of man... 21 U.S.C. 321 (g)( 1 XC). Statements
by petitioners and citations in the petition that cigarettes are used by smokers
to aect the structure or any functions of their bodies are not evidence of such
intent by the manufacturers or vendors of cigarettes.. .?~
The D.C. Circuit Court picked up on the same theme, but with an important
~' Statement of Dr. Edwards. supra note 21, at 239 (emphasis added). See
also Action on Smoking and Health v. Califano, Civ. No. 78-338 (D.C. Cir.
1979) (deferring to FDA Commissioner's interpretation that absent vendor's
assertion of therapeutic claim, no jurisdiction would be applied).
32 Dr. Kessler, despite his apparent change of policy, still stated in his
Feb. 25 1994 letter that: The FDA's fundamental position remains unchanged:
Tobacco is not a food and is not a drug and as such has special regulatory pro-
tection. FDA Considers Classication of Nicotine as Drug, CHIC. TRIBUNE,
Feb. 26, 1994, at 4.
33Actlon on Smoking and Health v. Harris, 655 F.2d 236 (DC Cir. 1980),
reprinted in Hutt & Merrill, FooD AND DRUG LAW 382 (2nd. ed, 1991).
~' Id.
~ Id (citing Letter from FDA Commissioner Donald Kennedy to Action on
Smoking and Health (Dec. 5, 1977)).
10~- (
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qualication:
Unlike petitioners, we do not read these statements to mean either that the
Commissioner will never consider evidence of consumer intent on this question...
Rather, by falling to introduce any evidence of vendor's intent - whether based
upon subjective vendor claims or objective evidence such as labeling, promo-
tional material, and advertising - ASH placed itself in the position of having to
meet the high standard established in cases where the statutory intent is derived
from consumer use alone. Clearly, It is well established that the 'intended use' of
a product, within the meaning of the Act, determined from Its label, accompa-
nying labeling, promotional claims, advertising, and any other relevant source.
Whether evidence of consumer intent is a relevant source for these purposes
depends upon whether such evidence is strong enough to justify an inference as
to the vendors intent. This requires a substantial showing... ~36
REGULATE {'IIE CNGARETFE AS A DEVICE UNDER THE
FD&C ACT
The FDA could possibly regulate a cigarette as a nicotine delivery system or
more simply as a device, as dened in section 20 1(h) of the FD&C Act, which
states, in pertinent part: [tihe term devlce' ... means Instruments, apparatus,
and contrivances, including their components, parts, and accessories, intended
... to aect the structure or any function of the body of man or other animals.37
Under section 5 13(a)( I )(C), cigarettes would certainly be categorized as
a Class III device, which would require pre-market approval before cigarettes
could be sold. The FD&C Act states, in relevant part:
ClASS m, PREMARKET APPROVAL. - A device which because -
(I) it (I) cannot be classied as a class I device because insucient
information exists to determine what the application of general controis are
sucient to provide reasonable assurance of the safety and eectiveness of the
device, and (II) cannot be classied as a class Ii device because insucient
information exists to determine what the specic controls ... would provide
reasonable assurance of its safety and eectiveness, and... (II) (II) presents a
potential unreasonable risk of Illness or injuiy, is to be subject, in accordance
with section 515, to pre-rnarket approval to provide reasonable assurance of its
safety and eectiveness?8
~ Id (emphasis added).
~ See, e.g., United States v. 23... ArtIcles, 192 F.2d 308(2nd CIr. 1951)
(describing the
application of x 201(h) to phonograph records intended to induce sleep),
reprinted in Hutt &
Merrill, supra note 33, at 723.
~ FD&C Act, x 513(aXIXC).
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Though this language clearly would endanger the contInued sale of cigarettes?9
the complexity of the process over and above that Involved in declaring nicotine
a drug would be substantial.~
As a matter of interest, It should be noted that many other forms of devices
which deliver nicotine to consumers are already regulated by the FDA.4' To say
that cigarettes are dierent is a legal ction, if it is assumed that nicotine Is
Intended to be addictive (as I will soon discuss).42
REGULATE NICOTINE AS A DRUG UNDER THE FD&C ACT
The other alternative oered by the FD&C Act, and certainly the more
promising in terms of regulating cigarettes, is to regulate nicotine as a drug.
~ Especially given the dictates of FD&C Act x 51 5(bX2), which states The
Secretary shall deny approval of an application for a device if ... the Secretary
nds that ... there is a lack of showing of reasonable assurance that such device
is safe under the conditions of use prescribed, recommended or suggested in the
proposed labeling thereof...
40 Dr. Kessler did raise the possibility of considering some cigarettes as
Thigh technology nicotine delivery devices in his March 25, 1994 testimony
before Congress. Schwartz, Kessler Tells Committee FDA May Act to Regulate
Tobacco Products' Content: Agency Wants Guidance from Congress, WASH.
POST, March 26, 1994, at A3. See also Schwartz, supra note 1, at Al; Feb. 25,
1994 letter, supra note 2.
~' Hutt & Merrill, supra note 33, at 381 n.2. See, e.g. Regulatory Letter No.
87-HFN-312-06 from Director of the Oce of Compliance in the FDA Center for
Drugs and Biologics D.L. Michels to Director of Advanced Tobacco Products
J.P. Ray (Feb. 9, 1987) (stating that Favor Smokeless Cigarettes, a hollow
paper tube with nicotine in the mouthpiece but containing no tobacco, was a
drug because it was represented to deliver an amount of nicotine comparable to
that of conventional cigarettes and to produce the same nervous system eects);
Hutt & Merrill, supra note 33, at 381 n.2. (stating that the FDA approved a
New Drug Application for Nicorette, which is indicated as a temporary aid to
the cigarette smoker seeking to give up his or her smoking habit...); Waldholz &
Helyar. FDA Feels Heat on Smokeless Cigarette, WALL ST. J., Oct. 21, 1988,
at Bi (stating a nicotine inhaler is a far more eective delivery mechanism for
an addictive drug than a cigarette); Health Consequences of Smoking: Nicotine
Addiction: Hearings Before the Subcomm. on Health and the Environment of
the House Comm. on Energy and Commerce, 100th Cong., 2d Sess., 163-64
(1988) (statement of Dr. John Slade) (stating that the nicotine inhaling device
will be the most addictive form of nicotine ever devised). See also Editorial, N.Y.
TIMES, Mar. 3, 1989, at A38 (stating that the withdrawal of RJR Nabisco's
Premier smokeless cigarette had prevented the FDA ~m declaring whether the
device would have been termed a drug delivery system.)
42 Proof of addiction destroys the foundation of the argument that cigarettes
are dierent and leave[s] lobbying power as the sole determinant of dierential
12treatment. O'Reilly. supra note 3, at 223.
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The FD&C Act denes a drug. in pertinent part, as articles (other than
food) intended to aect the structure of the body of man or other animals.
FD&C Act x 20 1(gX 1 )(C). To regulate cigarettes, therefore, the FDA must
demonstrate two elements: rst, that nicotine aects the structure of the body,
which can be proved by evidence of Its addictive quality; and, second, that
cigarette manufacturers intend for the addictive quality to be an element of
their product.
Anw'rs THE STHUCTURE OF THE BODY
In his February 25, 1994 letter to the chairman of an anti-smoking organi-
zation, FDA Commissioner Kessler stated that 77% of smokers desire to quit
but cannot, primarily because of nicotine addiction.~ Since the 1988 study of
nicotine addiction undertaken by the Surgeon General, such statements are un-
controversial.~ Addiction, as opposed to a habit, is, without question, an aect
on the structure of the body, as contemplated In FD&C Act's section 201(g)( 1
)(C).
Despite the strong evidence of the addictive quality of nicotine, Kessler ap-
pointed a special FDA panel to study the issue of nicotine addiction. By not
accepting the widespread view that nicotine was addictive and referring it to a
panel, Kessler demonstrated a willingness to question all the evidence support-
ing the regulation of nicotine as a drug, a tactic which certainly would make it
harder to dismiss the FDA's ndings as a rush to judgment. When the panel
reported back in August of 1994, the panel voted unanimously that the amount
of nicotine delivered by current cigarettes [is!
43Chen,supranote 10, atAl.
See THE HEALTH CONSEQUENCES OF SMOKING: NICOTINE ADDICTION-
A REPORT OF THE SURGEON
GENERAL, supra note 3, at I.
14w'
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likely to lead to addiction In the typical smoker.~ The ndings of the panel
were disputed by only the most adamant tobacco supporters but were hailed as
denitive by organizations such as the American Medical Association.~
Perhaps the most damaging information on the subject of addiction came
from within the tobacco industry itself.47 A 1963 document from British-American
Tobacco Company ies stated: Chronic intake of nicotine tends to restore
the normal physiological functioning of the endocrine system. so that ever-
increasing dose levels of nicotine are necessary to maintain the desired action.~
Another 1963 memo, which was from Brown & Williamson's General Counsel
Addison Yeaman, stated that We are, then, in the business of selling nicotine,
an addictive drug eective in the release of stress mechanisms.49 A supervisor
of research at Phillip Morris in 1972 wrote: 'Think of the cigarette pack as a
storage container for a day's supply of nicotine. Thing of the cigarette as a
dispenser of a dose unit of nicotine.~ In April of 1994, 2 former scientists for
Philip Morris testied to a House panel that:
their studies on rats more than a decade ago indicated that nicotine was
highly addictive. The laboratory was also working on [addictive] drugs that
could give nicotine's kick without Its harmful cardiovascular eects. Phillip
Morris kept the researchers from publishing the research and abruptly closed
down their
~~ Schwartz, supra note 18, at Al. The panel said that the 10-15 percent of
smokers who smoke 5 cIgarettes or fewer a day do not appear to be addicted.
Neal Benowitz of UCSF and David Sacha of the Paito Alto Center for Pulmonary
Disease Prevention believe[dl that 5 mg of nicotine a day would not addict
anyone. Id. Alice Young of Wayne State University pointed out that currently
addicted smokers might increase their intake of cigarettes (and thereby receive
a higher amount of tar) If the amount of nicotine in cigarettes were reduced.
Id. 46 A Growing Tide Against Smoking: AIvIA Urges Tobacco Be Viewed as
Addictive Drug. L.A. TIMES, June 8, 1994, at B4.
~ This chink in the armor of the tobacco industry has become a key factor
behind the tobacco regulation movement's success.
48 FDA Chief Says Nicotine is Bolstered Genetic, Chemical 'Manipulation'
of Tobacco by Companies Charged, BOS. GLOBE, June 22, 1994, at 1.
~ Schwartz, Internal Papers Fuel Tobacco Debate Cigarette Firms May Face
Turning Point in Regulation, Litigation, WASH. POST. May 14, 1994. at Al.
50 Schwartz, supra note 1, at Al.
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The tobacco industry had long contended that smokers chose their habit
freely; nicotine addiction, however, would eliminate that choice. Knowledge of
that fact raised serious questions about the intent of the tobacco companies.
INTENDED TO AFFECT
The FDA has long recognized that nicotine in tobacco produces druglike
eects, but that's not enough to give it jurisdiction;52 the second prong of the
test of x 20 1(g)( 1 )(C) must also be fullled, especially given the benet
of the doubt that the FDA has traditionally given cigarette manufacturers?8
As of this writing. Commissioner Kessler has not concluded whether cigarette
makers Intend to addict smokers to nicotine,~' but he did state in his Feb. 25.
1994 letter that evidence brought to our attention is accumulating that suggests
cigarette manufacturers may intend that their products contain nicotine.., to
achieve drug aects in some smokers.~ This evidence is exactly the kind of any
other relevant source that the D.C. Circuit in Action on Smoking arid Health
V. Hanis~ claimed could show intent on the part of tobacco manufacturers to
aect the structure of the body.
~' Id.
52 McGlnley, The Trials of Tobacco: What David Kessler Wants And How
He'll Try to Get It, WALL ST. J., June 23, 1994 at Bi.
'~' Kessler wrote in hIs Feb. 25, 1994 letter that the FDA has traditionally given
cigarette vendors the benet of the doubt as to whether they intend cigarettes
for this purpose, because some people smoke for other than the drug eect.
Schwartz, In Policy Shift, FDA is ready to Consider Regulating Tobacco, WASH.
POST, Feb. 26, 1994. at A4.
~ McGinley. supra note 52, at B 1. In my opinion, however, It is unlikely that
he will do so in the near future, as I will later discuss.
~ Schwartz, supra note 49, at Al.
56 655 F.2d 236 (DC CIr. 1980). Dr. Kessler has stated that, because tobacco
companies manipulate and control the level of nicotine in their cigarettes, such
evidence could be used as a kind of gauge of their intentions. McGinley, supra
note 52, at Bi.
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The evidence relating to Intent is, indeed, becoming quite substantial. Be-
sides the addiction data that the industry held back from the public, Dr. Kessler
suggested that the tobacco companies had experimented with high-nicotine to-
bacco plants, used ammonia to boost the impact of nicotine, and manipulated
nicotine levels because of its addictive quality.57 In his House Energy and Com-
merce subcommittee testimony, Commissioner Kessler stated that several to-
bacco companies had cultivated a specially-engineered high-nicotine yield to-
bacco plant, known as Y- 1. at overseas locations?6 He further accused Brown
& Williamson of formulating its cigarettes with a 10 percent portion of Y- I
leaves. In response, B&W admitted to having stored 3.5 mIllion pounds of im-
ported Y- 1 leaves in a U.S. warehouse, despite representations to the FDA,
only 2 months before, that it did not try to breed high-nicotine tobacco.
Dr. Kessler also asserted that FDA had evidence that many U.S. tobacco
companies inserted ammonia into cigarettes in order to 'almost double' the
amount of nicotine that gets into smokers' blood.6' The companies claimed
that ammonia merely adds to the avor or preserves the cigarettes.62 Kessler
responded by stating that the ndings lay to rest any notion that there is no
manipulation and control of nicotine undertaken in the tobacco industry.~
~ Let Congress Break the Tobacco Habit, supra note 25, at 14.
~ Monk, supra note 26, at Al.
59Id.
50Id.
61Id.
62Id
63Id
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The tobacco industry conceded that they have the technology to
control nicotine during the manufacturing process, but that it is used
only
to ensure the taste and to reduce levels of tar and other unhealthy materi-
als.6' The validity of such a claim was attacked openly by both Kessler and the
Congress. Kessler testied that cigarette company scientists had done research
that showed certain substances, including citric acid and spicy pepper extract,
could act as [taste! substitutes for nicotine, giving the same characteristic burn
in the throat.65
U.S. Rep. Henry Waxman produced a 1981 study by researcher Alexander
Spears, which indicated that companies have long manipulated the levels of
nicotine in cigarettes.~ Industry ocials have responded that their manipulation
of nicotine, rather than being based on some sinister intent, has attempted to
provide consistent products and conformity with
'federal truth-in-labeling requirements. 67 With the advent of low-tar
cigarettes, Spears testied to Waxman's House panel that nicotine has Increased
in direct relation to the decrease in tar?6 But FDA researchers and Spears's own
1981 study, found that nicotine and tar levels [are! not directly related and that
low-tar cigarettes providel] the highest yield of nicotine.6~ In direct contrast
to his Congressional testimony, Spears wrote in the 1981 study that: Current
research is directed toward increasing the nicotine levels while maintaining
or marginally reducing tar deliveries.70
64 Let Congress Break the Tobacco Habit, supra note 25, at 14
66 Schwartz, The Paradox: How Can Tobacco Ever Be Considered Safe? WASH.
POST, May 31,
1994, at All.
66 Schwartz, supra note 25, at A3.
67Id.
6SId
69Id.
70Id
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In Dr. Kessler's words, such evidence of past and current manufacturing
practices suggests that cigarette vendors intend the obvious-that many people
buy cigarettes to satisfy their nicotine addiction.7' If FDA concludes that this
is the case, the second prong of x 20 i(g]( I )(C) will be fullled and nicotine will
be concerned a drug for the purposes of the Federal Food, Drug and Cosmetic
Act of 1938.
DOEs 1113 FDA HAVE A DUTY TO B~w m DRUG NIco'rmE?
A few months after being conrmed as FDA Commissioner in 1990 David
Kessler held a strategy meeting concerning tobacco. At that meeting, he recog-
nized the diculty of asserting Jurisdiction over the product, especially when
some of the old hands stated simply It's a fool's mlssion.~ The majority present,
however, stated they were willing to take a shot.73 When the shot came in Febru-
ary of 1994, the defensive reaction of the tobacco companies was typied in the
statement: I don't know what they could be talking about.74 When Kessler
testied before Congress in March of 1994, that shot landed and made a deep
crater.
Kessler's approach was a well-calculated strategy. By writing to a leading
anti-smoking activist in February of 1994, he put that community on notice that
something was going to be done about smoking. But he might
have been doing something else: preventing a new petition to FDA
requesting
that the agency declare cigarettes a drug and ban them. In 1980, the D.C.
Circuit threw out a challenge to the FDA's decision not to regulate cigarettes
71 Schwartz, supra note 49, at Al.
72 Schwartz, supm note 1, at Al.
731d.
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as a drug, due to a lack of evidence concerning the manufacturers intent;Th
today, such information is much more plentiful, as I have described, and, in fact,
it seems quite possible that a reasonable trier of fact would conclude
that the tobacco industry, or at the very least parts of it, had the requisite intent.
Such a ruling would probably force FDA to ban cigarettes and would force
Congress, on the panic-stricken brink of a new age of prohibition, to produce
new legislation regulating cigarettes .~
In 1972, FDA Assistant General Counsel Peter Barton Hutt stated that
Congressional legislation was necessary to provide jurisdiction over cigarettes;
once jurisdiction was granted, cigarettes would have to banned pursuant to the
Federal Hazardous Substances Act.~ Though Dr. Kessler suggested in 1994
that he could foresee some type of regulation of cigarettes rather than an out-
right ban, it is clear from his careful testimony that he was aware that, if he
concluded nicotine is a drug, he would arguably have the statutory duty to ban
cigarettes.tm There are two possible ways Kessler could avoid banning cigarettes
and simply regulate them: get a Congressional directive or creatively read the
FD&C Act. For legitimacy reasons, the former is obviously much preferred to
the latter.
~' Id (statement of Walker Merryman, Director of Communications for the
Tobacco Institute). 75Actlon on Svnoldng and Health v. Harris, 655 F.2d 236
(DC CIr. 1980).
~ I think it Ia relatively uncontroversial to say that such times are not well-
suited to complex policy decLskms. It Is quite likely, actually, that the backlash
against the court's ruling would provide the smoking lobby to gain an outright
exemption for tobacco.
Statement of Mr. Hutt, supm note 21, at 245.
~ See Quindien, supra note 15, at 23. See also Statement of Dr. Edwards, supra
note 21, at 239 (if cigarettes were to be classied as drugs, they wouki have to
be removed from the market because it would be Impossible to prove they were
safe for their intended use). U.S. Rep. Thomas Bliley Jr.'s spokesman stated
that even though anti-tobacco forces insist they do not want to ban tobacco, 'if
they get It under the FDA it would be a de facto ban.' Schwartz, supra note 65,
at Al 1. U.S. Rep. Henry Waxman put it more bluntly: unless Congress acts,
FDA is going to have only one option: ban cigarettes, since the FDA cannot
approve a drug that Is known to be unsafe. Chen, supm note 10, at Al.
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Through his testimony of March 25, 1994 and his letter of Feb. 25, 1994,
CommIssioner Kessler sent an implicit warning to the Congress: Act or FDA
will. By demanding action, the Commissioner was able to shift attention away
from the traditional bad guy (the cigarette) and put the focus on nicotine and
the cigarette manufacturers. By threatening their livelihoods without actually
taking any action, Kessler, in eect, dared the tobacco giants to either propose
some system of reduced nicotine in cigarettes or seek an exemption from the
Congress from the FD&C Act.
Both Mr. Hutt and Dr. Kessler were asking the federal legislature to take
a stand on tobacco. In 1974, Mr. Hutt was stating, in eect, If you want FDA
to have jurisdiction over cigarettes, we will ban them, unless Congress gives
us some guidance. What Dr. Kessler is saying now is FDA will reluctantly
declare nicotine a drug and will attempt to regulate it (though there is a small
possibility we might have to ban it unless Congress gives us some guidance).
The implied threat of the latter and the direct line of the former both have the
same fundamental message to the Congress, take the lead on tobacco.~
By tempering his comments and stating that he could see simply regulating
tobacco, Kessler may have been trying to avoid all-out war with the tobacco
Industry, but, at the same time, he was recognizing a
fundamental truth: we cannot ban tobacco outright. Approxi-
mately 46 million Americans are smokers, and, of this number, we can estimate
that
~ In U.S. Rep. Henry Waxman's words, Kessler's position will require us to
do a lot of thinking and force Congress to gure out a more rational scheme for
handling tobacco. Chen,supranote 10, atAl.
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40 to 42 million of them are addicted to nicotine.~ Regulating tobacco alone
would have dramatic eects on society; banning tobacco would return us to
the nightmare of Prohibition with predictably similar results.8' For this reason,
during the last Congressional session, U.S. Representatives Richard Durbin,
Mike Synar, and Ron Wyden tried to attach an amendment to an agricultural
bill that would have given FDA authority over cigarettes.~ It failed.
FDA Commissioner David Kessler has to make that threat of FDA action
on cigarettes real again by turning up the rhetoric and forcing the Congress to
react?6 If he doesn't or if he tries to regulate nicotine without Congressional
support, it will be much more dicult for our society to break free of the nicotine
habit?'
~ See Schwartz, supra note 18, at Al.
81 McGinley, supra note 52, at Bi.
82 Clmons, eta), Quick House Vote Sought on Regulation of Tobacco- Congress:
The Legislation would require the FDA to control the substance but prohibit
the agency from banning cigarettes, LA. TIMEs, June 14, 1994, at A12.
83 Most likely with legislation similar to that proposed by Durbin,
Synar, and Wyden. Perhaps addiction would have been more appropriate, given
the latest revelations from
the tobacco industry.
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